Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion type Assertion NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_head.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion description "[Our data imply that a cancer-testis antigen, LY6K, should be useful as a new type of tumor biomarker and probably as a target for the development of new molecular therapies for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_provenance.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion evidence source_evidence_literature NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_provenance.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion SIO_000772 18089789 NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_provenance.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion wasDerivedFrom befree-20150227 NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_provenance.
- NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_assertion wasGeneratedBy ECO_0000203 NP913708.RApkVe5LOK22L8B3pxJ1cLkT6y6jBG6anOFXtbQZl2Eso130_provenance.